Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCAT1 | P54687 | 15/20 | 0.51 |
| ▸ | BCAT2 | O15382 | 14/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6263807 | 0.88 | BCAT1 (0.50) | BCAT1BCAT2 | |
| SCHEMBL27047526 | 0.88 | BCAT1 (0.52) | BCAT1BCAT2 | |
| SCHEMBL7233936 | 0.87 | LMNA (0.37) | BCAT1BCAT2LMNAFFAR1PTGDR2 | |
| SCHEMBL6248581 | 0.87 | BCAT1 (0.54) | BCAT1BCAT2 | |
| SCHEMBL6244770 | 0.86 | BCAT1 (0.53) | BCAT1BCAT2 | |
| SCHEMBL27047543 | 0.85 | BCAT1 (0.45) | BCAT1BCAT2FFAR1PTGDR2 | |
| SCHEMBL27047576 | 0.85 | PTGDR2 (0.43) | BCAT1BCAT2PTGDR2 | |
| SCHEMBL7227999 | 0.84 | BCAT1 (0.47) | BCAT1BCAT2 | |
| SCHEMBL27047561 | 0.84 | BCAT2 (0.42) | BCAT1BCAT2PTGDR2 | |
| SCHEMBL27044949 | 0.82 | BCAT1 (0.50) | BCAT1BCAT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6667413-B2 | Aniline derivatives; herbicides; nonphytotoxic | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-12-23 | — | — | US | disclosed |
| US-20030130124-A1 | Herbicides | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-07-10 | — | — | US | disclosed |
| US-6451740-B2 | HERBICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-09-17 | — | — | US | disclosed |
| US-20020013466-A1 | Uracil compounds and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2002-01-31 | — | — | US | disclosed |
| EP-1106607-A2 | Uracil compounds and their use | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2001-06-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030130124-A1 | Herbicides | CBR3, CBR1, MT-CO1 | BCAT1 492/4885BCAT2 650/4885LMNA 2498/4885 |
| US-20020013466-A1 | Uracil compounds and use thereof | UNG, MRM1, OGG1 | BCAT1 450/4885BCAT2 648/4885LMNA 2074/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.